About Kashiv Specialty Pharmaceuticals
Kashiv Specialty Pharmaceuticals is a company based in Bridgewater (United States) founded in 2020 was acquired by Amneal in January 2021.. Kashiv Specialty Pharmaceuticals offers products and services including Drug Delivery Technologies. Kashiv Specialty Pharmaceuticals operates in a competitive market with competitors including Moderna, BridgeBio, Spark Therapeutics, Rhythm Pharmaceuticals and Horizon Therapeutics, among others.
- Headquarter Bridgewater, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Kashiv Specialty Pharmaceuticals, Llc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kashiv Specialty Pharmaceuticals
Kashiv Specialty Pharmaceuticals offers a comprehensive portfolio of products and services, including Drug Delivery Technologies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Innovative solutions for effective and specialized drug delivery methods.
Funding Insights of Kashiv Specialty Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Kashiv Specialty Pharmaceuticals
Kashiv Specialty Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Amneal. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manufacturer of generics formulations
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Kashiv Specialty Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Kashiv Specialty Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Kashiv Specialty Pharmaceuticals Comparisons
Competitors of Kashiv Specialty Pharmaceuticals
Kashiv Specialty Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BridgeBio, Spark Therapeutics, Rhythm Pharmaceuticals and Horizon Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies
|
|
| domain | founded_year | HQ Location |
Developer of drugs for treating rare and autoimmune diseases
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Kashiv Specialty Pharmaceuticals
Frequently Asked Questions about Kashiv Specialty Pharmaceuticals
When was Kashiv Specialty Pharmaceuticals founded?
Kashiv Specialty Pharmaceuticals was founded in 2020.
Where is Kashiv Specialty Pharmaceuticals located?
Kashiv Specialty Pharmaceuticals is headquartered in Bridgewater, United States. It is registered at Bridgewater, New Jersey, United States.
What does Kashiv Specialty Pharmaceuticals do?
Kashiv Specialty Pharmaceuticals was founded in 2020 and is based in Bridgewater, United States. Focus is placed on the pharmaceutical sector, where therapeutic solutions for rare diseases are developed. Operations include the advancement of drug candidate K127 for myasthenia gravis and skeletal muscle weakness. Additional candidates, such as K129 for ADHD, K128 for sialorrhea and movement disorders, and K114 for hypothyroidism, are created using proprietary drug delivery technology.
Who are the top competitors of Kashiv Specialty Pharmaceuticals?
Kashiv Specialty Pharmaceuticals's top competitors include Moderna, Spark Therapeutics and BridgeBio.
What products or services does Kashiv Specialty Pharmaceuticals offer?
Kashiv Specialty Pharmaceuticals offers Drug Delivery Technologies.
Who are Kashiv Specialty Pharmaceuticals's investors?
Kashiv Specialty Pharmaceuticals has 1 investor. Key investors include Amneal.